12.18.23 OMA Board Book

a. Since the last meeting, the IHO team has developed strategies around obesity and these strategies have been forwarded to AMA leadership for consideration and implementation. b. Janet attended the ACP meeting, at which the internists along with all the subspecialties want to empower equitable obesity care, and are wanting to develop guidelines around this. It was suggested perhaps Janet could facilitate interaction between obesity caucus groups such as OMA, ASMBS, The Endocrine Society and AACE to work in conjunction with ACP on such guidelines. c. Janet will be attending the National Council on Aging meeting, and reviewing action steps to break down barriers to care for older individuals with obesity. 4) Dr. John Scott, ASMBS a. Dr. Scott discussed how he is working with ASMBS and IHO to implement strategies to eliminate insurance bias for people with obesity for evidence-based treatments including metabolic and bariatric surgery. He points out that these denials and delays would not be tolerated for any other disease state. b. The current strategy being employed by ASMBS is to target specific states. ASMBS is reaching out to state medical associations, explaining the problem, and trying to start with one issue: a state law, an unfair insurer, etc. If there are roadblocks, the AMA can assist those state societies. c. The AMA has provided an issue brief around the topics of “What is the problem?” “How can we address it?” This has been drafted by the IHO team which the states can then use and customize to their unique situation. d. If they are successful in implementing the proposed changes in these 11 states, it could impact over 26 million Americans living with obesity. 5) TROA a. Chris Gallagher was in attendance as well. Janet did state that the AMA continues to support TROA, however, she was not sure if the AMA has supported TROA in the current congress. We requested that the AMA send an additional letter of support to congress, and inquired on AMA’s interest to be signed on to a coalition letter. Chris also discussed a successful advocacy effort in North Carolina. In North Carolina, state employees had coverage for AOMs, but the state was going to eliminate coverage due to the expenses of GLP-1s. Educating that the purchase price for the insurance was dramatically less than the list price convinced the state of North Carolina to retain coverage for patients. 6) Carolynn Francavilla-Brown, MD OMA BOT and Colorado Alternate Delegate a. Dr. Francavilla-Brown updated the group on a resolution she put forth through the private practice physicians. She states providers are receiving notifications from CVS that their patients might be diverted to CVS-run programs for lifestyle coaching and possibly management of their AOMs. This resolution calls on the AMA to oppose this, and Dr. Francavilla-Brown asked caucus members to testify in support of this resolution. 7) Resolutions 806 and 820: These resolutions call for universal support of evidence-based anti obesity medications without carveouts. The caucus was asked to support these resolutions as well. 8) Brainstorming session: Dr Lazarus asked attendees if there would be an interest in a resolution calling on the AMA to oppose non-FDA approved and potentially unsafe

Page | 2